Literature DB >> 35939114

Radiomics based on enhanced CT for differentiating between pulmonary tuberculosis and pulmonary adenocarcinoma presenting as solid nodules or masses.

Wenjing Zhao1, Ziqi Xiong1, Yining Jiang1, Kunpeng Wang2, Min Zhao3, Xiwei Lu4, Ailian Liu1, Dongxue Qin5, Zhiyong Li6.   

Abstract

PURPOSE: To investigate the incremental value of enhanced CT-based radiomics in discriminating between pulmonary tuberculosis (PTB) and pulmonary adenocarcinoma (PAC) presenting as solid nodules or masses and to develop an optimal radiomics model.
METHODS: A total of 128 lesions (from 123 patients) from three hospitals were retrospectively analyzed and were randomly divided into training and test datasets at a ratio of 7:3. Independent predictors in subjective image features were used to develop the subjective image model (SIM). The plain CT-based and enhanced CT-based radiomics features were screened by the correlation coefficient method, univariate analysis, and the least absolute shrinkage and selection operator, then used to build the plain CT radiomics model (PRM) and enhanced CT radiomics model (ERM), respectively. Finally, the combined model (CM) combining PRM and ERM was established. In addition, the performance of three radiologists and one respiratory physician was evaluated. The areas under the receiver operating characteristic curve (AUCs) were used to assess the performance of each model.
RESULTS: The differential diagnostic capability of the ERM (training: AUC = 0.933; test: AUC = 0.881) was better than that of the PRM (training: AUC = 0.861; test: AUC = 0.756) and the SIM (training: AUC = 0.760; test: AUC = 0.611). The CM was optimal (training: AUC = 0.948; test: AUC = 0.917) and outperformed the respiratory physician and most radiologists.
CONCLUSIONS: The ERM was more helpful than the PRM for identifying PTB and PAC that present as solid nodules or masses, and the CM was the best.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Computed tomography; Machine learning; Pulmonary adenocarcinoma; Pulmonary tuberculosis; Radiomics

Year:  2022        PMID: 35939114     DOI: 10.1007/s00432-022-04256-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.322


  45 in total

1.  Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.

Authors:  Jooae Choe; Sang Min Lee; Kyung-Hyun Do; Seonok Kim; Sehoon Choi; June-Goo Lee; Joon Beom Seo
Journal:  Eur Radiol       Date:  2020-04-30       Impact factor: 5.315

Review 2.  The pulmonary nodule: clinical and radiological characteristics affecting a diagnosis of malignancy.

Authors:  L Cardinale; F Ardissone; S Novello; M Busso; F Solitro; M Longo; D Sardo; M Giors; C Fava
Journal:  Radiol Med       Date:  2009-05-29       Impact factor: 3.469

3.  Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas.

Authors:  Niha Beig; Mohammadhadi Khorrami; Mehdi Alilou; Prateek Prasanna; Nathaniel Braman; Mahdi Orooji; Sagar Rakshit; Kaustav Bera; Prabhakar Rajiah; Jennifer Ginsberg; Christopher Donatelli; Rajat Thawani; Michael Yang; Frank Jacono; Pallavi Tiwari; Vamsidhar Velcheti; Robert Gilkeson; Philip Linden; Anant Madabhushi
Journal:  Radiology       Date:  2018-12-18       Impact factor: 11.105

Review 4.  Tuberculosis: a radiologic review.

Authors:  Joshua Burrill; Christopher J Williams; Gillian Bain; Gabriel Conder; Andrew L Hine; Rakesh R Misra
Journal:  Radiographics       Date:  2007 Sep-Oct       Impact factor: 5.333

5.  A CT-based radiomics nomogram for prediction of lung adenocarcinomas and granulomatous lesions in patient with solitary sub-centimeter solid nodules.

Authors:  Xiangmeng Chen; Bao Feng; Yehang Chen; Kunfeng Liu; Kunwei Li; Xiaobei Duan; Yixiu Hao; Enming Cui; Zhuangsheng Liu; Chaotong Zhang; Wansheng Long; Xueguo Liu
Journal:  Cancer Imaging       Date:  2020-07-08       Impact factor: 3.909

6.  Radiomics model for distinguishing tuberculosis and lung cancer on computed tomography scans.

Authors:  E-Nuo Cui; Tao Yu; Sheng-Jie Shang; Xiao-Yu Wang; Yi-Lin Jin; Yue Dong; Hai Zhao; Ya-Hong Luo; Xi-Ran Jiang
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

7.  Radiomics signature on CECT as a predictive factor for invasiveness of lung adenocarcinoma manifesting as subcentimeter ground glass nodules.

Authors:  Ming Li; Yanqing Hua; Wufei Chen; Dingbiao Mao; Xiaojun Ge; Jiaofeng Wang; Mingyu Tan; Weiling Ma; Xuemei Huang; Jinjuan Lu; Cheng Li; Hao Wu
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

8.  Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study.

Authors:  Bin Ai; Li Zhang; Dingzhi Huang; Jun Chen; Zhe Liu; Xingsheng Hu; Shengyu Zhou; Yi Hu; Jun Zhao; Fan Yang
Journal:  Thorac Cancer       Date:  2020-10-19       Impact factor: 3.500

9.  Analysis of risk factors for stage I lung adenocarcinoma using low-dose high-resolution computed tomography.

Authors:  Rui Fang; Yong Yang; Haicheng Han; Xiaoqing Fu; Liwen Dong; Baisheng Xie; Wei Lu; Chenyang Ma; Feng Cui; Jian Hu; Jun Wang
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

10.  Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study.

Authors:  Xiaofeng Chen; Zhiqi Yang; Jiada Yang; Yuting Liao; Peipei Pang; Weixiong Fan; Xiangguang Chen
Journal:  Cancer Imaging       Date:  2020-04-05       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.